Gender bias in nineteenth-century England: Evidence from factory children

Gender bias against girls in nineteenth-century England has received much interest but establishing its existence has proved difficult. We utilise data on heights of 16,402 children working in northern textile factories in 1837 to examine whether gender bias was evident. Current interpretations argue against any difference. Here our comparisons with modern height standards reveal greater deprivation for girls than for boys. Discrimination is measured in girls’ height-for-age score (HAZ) falling eight standard errors below boys’ at ages 11, 11.5 and 12 years of age, capturing the very poor performance of factory girls. But this result cannot be taken at face value. We query whether modern standards require adjustment to account for the later timing of puberty in historical populations and develop an alternative. We also test the validity of the age data, considering whether parents were more prone to lie about the ages of their daughters, and question whether the supply of girls was fundamentally different from that of boys. We conclude that neither proposition is justified. Disadvantage to girls remains, although its absence amongst younger children precludes an indictment of culturally founded gender bias. The height data must remain mute on the source of this discrimination but we utilise additional information to examine some hypotheses: occupational sorting, differential susceptibility to disease, poorer nutrition for girls, disproportionate stunting from the effects of nutritional deprivation, and type and amount of work undertaken. Of these we suggest that girls had to do arduous physical labour in the home alongside their factory work. The only (unsubstantiated) alternative is that girls were more likely than boys to be put into factory work below the legal age limit. Both represent forms of gender bias.     

Gender difference of unconscious attentional bias in high trait anxiety individuals

By combining binocular suppression technique and a probe detection paradigm, we investigated attentional bias to invisible stimuli and its gender difference in both high trait anxiety (HTA) and low trait anxiety (LTA) individuals. As an attentional cue, happy or fearful face pictures were presented to HTAs and LTAs for 800 ms either consciously or unconsciously (through binocular suppression). Participants were asked to judge the orientation of a gabor patch following the face pictures. Their performance was used to measure attentional effect induced by the cue. We found gender differences of attentional effect only in the unconscious condition with HTAs. Female HTAs exhibited difficulty in disengaging attention from the location where fearful faces were presented, while male HTAs showed attentional avoidance of it. Our results suggested that the failure to find attentional avoidance of threatening stimuli in many previous studies might be attributed to consciously presented stimuli and data analysis regardless of participants' gender. These findings also contributed to our understanding of gender difference in anxiety disorder.     

Gender bias in the effects of arms and countermovement on jumping performance

The ability to jump high is considered important in a number of sports. It is commonly accepted that the use of the arms and a counter movement increase jump height. In some sport situations (e.g., volley ball block, basketball rebound), athletes may not be able to utilize a counter movement or arm swing. The purpose of this study is to examine gender differences in the contribution of the arm swing and counter movement to vertical jump height. Fifty college students, 25 men (age = 21.4 +/- 1.7 years, height = 182.2 +/- 8 cm, weight = 83.7 +/- 12.4 kg) and 25 women (age = 20.7 +/- 1.6 years, height = 166.7 +/- 6.3 cm, weight = 61.5 +/- 7.0 kg), performed 4 jumping movements: squat jumps with hands on hips (SNA), counter movement jump with hands on hips (CMNA), squat jump with arm swing (SA), and counter movement with arm swing (CMA). Significant differences were found between men's and women's performance, as well as between each type of jump within each gender. A mixed-model analysis of variance detected gender differences with respect to changes in the jumping movement. For both sexes the jumps in order from worst to best were SNA, CMNA, SA, and CMA. Peak power values for men were 4,057, 4,020, 4,644, and 4,747 W, respectively, for the 4 jumps. The female power values were 2,543, 2,445, 2,842, and 2,788 W, respectively, for the 4 jumps. Arms increased jump height more than a counter movement for both genders, with jump heights for men at 29.6, 31, 36, and 38 cm, respectively, and those of women 21, 22, 26, and 27 cm, respectively. Use of the arms was found to increase the jump height of the men significantly more than that of women. Changes in jumping movements affect men and women differently. The greater increase in jump height for the men when using the arm swing could be because of greater upper body strength of men compared with women. This could have applications to training and upper body strength and also to modeling of jumping movements.     

Gender bias in jumping kinetics in National Collegiate Athletic Association Division I basketball players

The purposes of this study are to examine gender differences in the contribution of the arm swing to jump height in men and women basketball players and to examine the role of upper-body strength in the contribution of arm swing to jump height. National Collegiate Athletic Association Division I basketball players (men n = 13, women n = 12) performed 4 jumping movements: squat jumps with hands on hips (SNA) and with arm swings (SA) and countermovement jumps with hands on hips and with arm swings (CMA). Differences were found between the jump heights of men and women. Use of the arms increased the jump height of men more than women. Compared with the SNA, the SA allowed an increase of 7 cm (23%) for men and 4 cm (17%) for women. The CMA allowed for an increase of 10 cm (30%) for men and 6 cm (24%) for women. General upper-body strength measures did not correlate strongly with the effect of arms on jumping, but peak power did. As in previous studies, peak power had a high correlation with jumping performance. These results show that the arm swing contributes significantly to jump performance in both men and women basketball players and that strength training for jumping should focus on power production and lifting exercises that are jump specific.     

Gender bias in Theiler's virus-induced demyelinating disease correlates with the level of antiviral immune responses

Multiple sclerosis is an immune-mediated disease of the CNS and shows a sex-biased distribution in which 60-75% of all cases are female. A mouse model of multiple sclerosis, Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease, also displays a gender bias. However, in the C57L/J strain of mice, males are susceptible to disease whereas females are completely resistant. In this study we determined the gender differences in the TMEV-specific immune response, which may be responsible for the gender bias in clinical disease. Our data clearly demonstrate that female C57L/J mice induce significantly higher levels of TMEV-specific neutralizing Ab as well as a stronger peripheral T cell response throughout the course of viral infection. In contrast, male mice have a higher level of TMEV-specific CD4(+) and CD8(+) T cell infiltration into the CNS as well as viral persistence. These results suggest that a higher level of the initial antiviral immune response in female mice may be able to effectively clear virus from the periphery and CNS and therefore prevent further disease manifestations. Male mice in contrast do not mount as effective an immune response, thereby allowing for eventual viral persistence in the CNS and continuous T cell expansion leading to clinical symptoms.     

Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome

Fibromyalgia (FM) pain is frequent in the general population but its pathogenesis is only poorly understood. Many recent studies have emphasized the role of central nervous system pain processing abnormalities in FM, including central sensitization and inadequate pain inhibition. However, increasing evidence points towards peripheral tissues as relevant contributors of painful impulse input that might either initiate or maintain central sensitization, or both. It is well known that persistent or intense nociception can lead to neuroplastic changes in the spinal cord and brain, resulting in central sensitization and pain. This mechanism represents a hallmark of FM and many other chronic pain syndromes, including irritable bowel syndrome, temporomandibular disorder, migraine, and low back pain. Importantly, after central sensitization has been established only minimal nociceptive input is required for the maintenance of the chronic pain state. Additional factors, including pain related negative affect and poor sleep have been shown to significantly contribute to clinical FM pain. Better understanding of these mechanisms and their relationship to central sensitization and clinical pain will provide new approaches for the prevention and treatment of FM and other chronic pain syndromes.     

Biology and therapy of fibromyalgia. New therapies in fibromyalgia

Fibromyalgia is a chronic, musculoskeletal pain condition that predominately affects women. Although fibromyalgia is common and associated with substantial morbidity and disability, there are no US Food and Drug Administration-approved treatments. However, progress has been made in identifying pharmacological and non-pharmacological treatments for fibromyalgia. Recent pharmacological treatment studies have focused on selective serotonin and norepinephrine reuptake inhibitors, which enhance serotonin and norepinephrine neurotransmission in the descending pain pathways and lack many of the adverse side effects associated with tricyclic medications. Promising results have also been reported for medications that bind to the α₂δ subunit of voltage-gated calcium channels, resulting in decreased calcium influx at nerve terminals and subsequent reduction in the release of several neurotransmitters thought to play a role in pain processing. There is also evidence to support exercise, cognitive behavioral therapy, education, and social support in the management of fibromyalgia. It is likely that many patients would benefit from combinations of pharmacological and non-pharmacological treatments, but more study is needed.     

Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia

Techniques in neuroimaging such as functional magnetic resonance imaging (fMRI) have helped to provide insights into the role of supraspinal mechanisms in pain perception. This review focuses on studies that have applied fMRI in an attempt to gain a better understanding of the mechanisms involved in the processing of pain associated with fibromyalgia. This article provides an overview of the nociceptive system as it functions normally, reviews functional brain imaging methods, and integrates the existing literature utilizing fMRI to study central pain mechanisms in fibromyalgia.     

Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome

Researchers studying fibromyalgia strive to identify objective, measurable biomarkers that may identify susceptible individuals, may facilitate diagnosis, or that parallel activity of the disease. Candidate objective measures range from sophisticated functional neuroimaging to office-ready measures of the pressure pain threshold. A systematic literature review was completed to assess highly investigated, objective measures used in fibromyalgia studies. To date, only experimental pain testing has been shown to coincide with improvements in clinical status in a longitudinal study. Concerted efforts to systematically evaluate additional objective measures in research trials will be vital for ongoing progress in outcome research and translation into clinical practice.     

Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome

Genetic and environmental factors may play a role in the etiopathology of fibromyalgia syndrome (FMS) and other related syndromes. There is a high aggregation of FMS in families of FMS patients. The mode of inheritance is unknown but it is most probably polygenic. There is evidence that polymorphisms of genes in the serotoninergic, dopaminergic and catecholaminergic systems play a role in the etiology of FMS. These polymorphisms are not specific for FMS and are associated with other functional somatic disorders and depression. Future genetic studies in the field of FMS and related conditions should be conducted in larger cohorts of patients and ethnically matched control groups.     

Paraoxonase and arylesterase activities in fibromyalgia

We aimed to evaluate the association of serum paraoxonase and arylesterase activities and oxidative/antioxidative status in patients with fibromyalgia. Forty-two patients with fibromyalgia and 53 healthy controls were included in the study. Serum paraoxonase and arylesterase activities were measured spectrophotometrically. Oxidative and antioxidative status were evaluated by measuring serum lipid hydroperoxide (LOOH) levels, total antioxidant status (TAS) and free sulfhydryl groups (-SH = total thiol). Lipid parameters were determined by routine laboratory methods. Serum paraoxonase and arylesterase activities, and TAS were lower in patients with fibromyalgia than in controls (P < 0.001, for all), and the -SH level was also lower in the patient group (P = 0.03). LOOH levels were higher in the patient group than in controls (P = 0.01). Our results suggest that patients with fibromyalgia were exposed to oxidative stress, and paraoxonase and arylesterase activities were decreased in these patients. Patients with fibromyalgia might be prone to development of atherosclerosis with reduced paraoxonase and arylesterase activities.     

Autonomic dysfunction in women with fibromyalgia

Fibromyalgia (FM) is an idiopathic disease characterized by widespread pain and a myriad of symptoms. Symptoms are diverse and include not only pain but also anxiety, depression, orthostatic intolerance, and cold intolerance. While the etiology of FM is not fully understood, data have suggested that FM may stem from dysfunction of the autonomic nervous system. This dysfunction has been reported at rest, and after a physiological stressor such as exercise. However, few studies have examined the responses during exercise. This novel approach may shed some new light on the effect of exercise in women with FM.     

Animal models of fibromyalgia

Animal models of disease states are valuable tools for developing new treatments and investigating underlying mechanisms. They should mimic the symptoms and pathology of the disease and importantly be predictive of effective treatments. Fibromyalgia is characterized by chronic widespread pain with associated co-morbid symptoms that include fatigue, depression, anxiety and sleep dysfunction. In this review, we present different animal models that mimic the signs and symptoms of fibromyalgia. These models are induced by a wide variety of methods that include repeated muscle insults, depletion of biogenic amines, and stress. All potential models produce widespread and long-lasting hyperalgesia without overt peripheral tissue damage and thus mimic the clinical presentation of fibromyalgia. We describe the methods for induction of the model, pathophysiological mechanisms for each model, and treatment profiles.     

Review of pharmacological therapies in fibromyalgia syndrome

This review addresses the current status of drug therapy for the management of fibromyalgia syndrome (FMS) and is based on interdisciplinary FMS management guidelines, meta-analyses of drug trial data, and observational studies. In the absence of a single gold-standard medication, patients are treated with a variety of drugs from different categories, often with limited evidence. Drug therapy is not mandatory for the management of FMS. Pregabalin, duloxetine, milnacipran, and amitriptyline are the current first-line prescribed agents but have had a mostly modest effect. With only a minority of patients expected to experience substantial benefit, most will discontinue therapy because of either a lack of efficacy or tolerability problems. Many drug treatments have undergone limited study and have had negative results. It is unlikely that these failed pilot trials will undergo future study. However, medications, though imperfect, will continue to be a component of treatment strategy for these patients. Both the potential for medication therapy to relieve symptoms and the potential to cause harm should be carefully considered in their administration.The desire to take medicine is perhaps the greatest feature which distinguishes man from animals.Sir William Osler (1849–1919)